Facile and green synthesis of graphene oxide by electrical exfoliation of pencil graphite and gold nanoparticle for non-enzymatic simultaneous sensing of ascorbic acid, dopamine and uric acid

Habibulla Imran, Palinci Nagarajan Manikandan and Venkataraman Dharuman*
Molecular Electronics Laboratory, Department of Bioelectronics and Biosensors, Science Campus, Alagappa University, Karaikudi - 630004, India. E-mail: dharumanudhay@yahoo.com; Fax: +91-4565-225525; Tel: +91-4565-223361

Received 18th June 2015 , Accepted 13th July 2015

First published on 13th July 2015


Abstract

Pencil graphite is electrochemically exfoliated to obtain few layered graphene oxide (GO) in hydrochloric acid (HCl, HGO), sodium hydroxide (NaOH, NGO) and phosphate buffer saline (PBS, pH 7.4, PGO) media at a constant potential (+7.0 V) without ionic liquid for the first time. Thus, obtained graphene oxide is deposited (by drop casting and electro reduction) onto a glassy carbon electrode (GCE). Following this, gold nanoparticles (AuNP) are electro deposited to form a GO–AuNP composite for simultaneous discrimination of dopamine (DA), ascorbic acid (AA) and uric acid (UA) at pH 7.4. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques reveal well separated oxidation peaks for DA, AA and UA. The sensor surfaces are characterized by ultraviolet visible (UV-vis), photoluminescence (PL), X-ray diffraction (XRD), contact angle goniometry (CA) and scanning electron microscopy (SEM) techniques. DA, AA and UA are studied individually to evaluate the dynamic ranges and lowest detection limits of the sensor by the DPV method. Concentrations of DA, AA and UA in real samples viz., dopamine injection, vitamin C tablets and human urine are evaluated.


1. Introduction

Neuro transmitters dopamine (DA), ascorbic acid (AA) and uric acid (UA) co-exist in biological samples and change in their concentration levels beyond the critical limits (above micro molar concentration), leading to several health disorders. For instance, while variation in DA concentration affects brain function and induces neurological disorders like Parkinson’s disease and drug addiction,1–4 abnormal levels of UA (UA) regulate gout and hyperuricemia5,6 and changes in AA concentration affect the skin and immune system.7 Since these substrates regulate different diseases and are interrelated with each other, simultaneous detection of concentration levels of DA, UA and AA is of high interest in biomedical chemistry, neurochemistry, diagnostic and pathological investigations. Although various techniques including liquid chromatography,8 mass spectrometry9 spectrophotometry10 and electrochemical techniques11–13 are used for sensitive and selective detection, the electrochemical method is extensively investigated for its simplicity, cost-effectiveness and user friendliness.14–16 However, most of the reported sensors focus on the single analyte detection of either DA or AA for two reasons. (i) All these three analytes have similar oxidation potentials and sensor signals overlap each other.14–16 (ii) The DA poisons the surface by its adsorption on the carbon surface. Therefore, during the last five decades, intense research is directed towards the development of sensitive electrodes for lower concentrations (0.01 to 1 μM) of DA in the presence of 100 to 1000 fold excess of AA and UA.

Currently, graphene with metal/polymer composites is being applied in nanoelectronics, sensors, nanocomposites, batteries and super capacitors due to the increase in its intrinsic properties like electrical, thermal conductivity,17 optical,18 specific surface area,19 biocompatibility,20,21 mechanical strength and transparency.22 Metal,23 metal oxide,24,25 carbon nano structure26–28 and polymer16,29,30 decorated graphene are reported for simultaneous determination of DA, AA, and UA.31–34 Graphene is conventionally prepared by different routes such as thermal decomposition on a SiC wafer under ultrahigh vacuum (UHV),35–38 CVD growth on metal substrates (ruthenium,39 Ni,39,40 and Cu41), substrate-free CVD,42 and chemical43–47 and thermal reduction48 of graphite. Compared to mechanical exfoliation,49,50 thermal decomposition,51 oxidation of graphite52 liquid-phase exfoliation of graphite53,54 from single or few-layer graphene, the electroreduction55,56 produces thick layered graphenes. Surfactants, polymers and metal nanoparticles57–60 are suggested to avoid restacking. Since AuNP is more biocompatible and has tunable electronic properties, Li et al.61,62 have developed graphene–AuNP for the selective determination of DA with a detection limit of 1.86 μM. One-step solvothermal synthesis of graphene–AuNP composite is reported for simultaneous detection of DA, AA and UA.63,64 Although electrochemical exfoliation of graphite in the presence of ionic liquid is reported,65 avoiding toxic and expansive chemicals and simplifying the product recovery processes is essential. In this regard, electrical exfoliation in NaOH has recently been reported, but used H2O2 for GO reduction66 and has not been applied for any neurotransmitter detection. Therefore, this study aims to exploit the exfoliation of graphene in an aqueous medium, as there is no report available on the use of electrochemically exfoliated graphene oxide and gold nanoparticle composite until now for simultaneous sensing of DA, AA and UA. The graphene oxide is prepared by the electric exfoliation of pencil graphite in hydrochloric acid, phosphate buffer and sodium hydroxide, without using any ionic liquid or metal/metal oxide to prevent aggregation/restacking of graphene oxides. The thus obtained GO is deposited on the glassy carbon electrode surface by two different methods, viz. drop casting and electrochemical reduction of GO on the GCE. This is followed by gold nanoparticle deposition by electro reduction of HAuCl3·nH2O. Simultaneous detection of DA, AA and UA is made with and without gold nanoparticle decoration and compared.

2. Experimental section

2.1. Materials and methods

A pencil was used as a graphite rod (0.7 mm diameter and 60 mm length, purchased from a stationery shop). Potassium ferrocyanide, potassium ferricyanide, sulfuric acid, sodium chloride, dimethylformamide (DMF), sodium dihydrogen phosphate and potassium chloride of analytical grade were purchased from Himedia, India. Tetrachloroaurate was purchased from Sigma Aldrich, USA. Analytical grade dopamine, uric acid and ascorbic acid were all purchased from Sisco Research Laboratories Chemicals Pvt. Ltd. India. Milli-Q water (18.2 MΩ) was used for all experiments. 0.01 M phosphate buffer of pH 7.4 containing NaCl (120 mM), NaH2PO4 (10 mM) and KCl (2.7 mM) was prepared and used for all electrochemical experiments.

A pH meter from Susima, AP-1PLVS, India, was used for measuring the solution pH. The electrochemical experiments cyclic voltammetry (CV), chronoamperometry (CA) and differential pulse voltammetry (DPV) were carried out using the CHI 440B electrochemical analyzer/workstation (CH Instruments, USA). A conventional three-electrode system consisting of a glassy carbon working electrode (3 mm diameter), a platinum wire (1 mm diameter and 2 cm long) counter electrode and an Ag/AgCl reference electrode was used. A PANalytical make Bruker D8-Advance powder diffractometer, which uses Cu-Kα1 radiation (2.2 kW max), was used for powder X-ray diffraction measurements (PANalytical B.V., Lelyweg 1, 7602 EA ALMELO, The Netherlands). Chemical vapor deposited gold (100 nm) Si and graphite substrates were used for acquiring the SEM images and EDS spectra using a Zeiss SEM instrument, which uses a LEO 1530 field emission (Hitachi model S-3000H, Japan). Images were recorded at an accelerating voltage 10 kV with a secondary electron detector. A homemade variable DC power supply with a digital electronic multimeter was used for electrochemical exfoliation. UV spectra were recorded using a Shimadzu UV2450 high-performance single monochromator instrument in the frequency range 400–700 nm. The contact angle equipment was purchased from AST Products Inc., USA, having an automated model of VCA Optima XE.

2.2. Electrochemical exfoliation of pencil graphite

Graphene oxide was prepared from a pencil rod electrochemically by applying a constant DC potential +7 V between two pencil electrodes in an aqueous solution without any ionic liquids (Scheme 1).
image file: c5ra11723b-s1.tif
Scheme 1 Electrochemical exfoliation of a pencil to form graphene oxide and its anchoring on a glassy carbon electrode by drop casting (left) and electro reduction (right), followed by gold nanoparticle deposition for simultaneous sensing of dopamine (DA), ascorbic acid (AA) and uric acid (UA).

Three different aqueous media viz., hydrochloric acid (HCl, named as HGO), phosphate buffer saline (PBS, pH 7.4, named as PGO), and sodium hydroxide (NaOH, named as NGO) were used for exfoliation. The exfoliation takes place at the positive terminal and graphene oxides were formed as flakes. The exfoliation process was completed in time scale, depending on the medium used and the formation of different amounts of graphene oxide. For instance, the amounts of graphene oxide formed are 760 μg A−1 s−1, 33.6 μg A−1 s−1 and 667 μg A−1 s−1, respectively, in HCl, NaOH and PBS media. The exfoliation rate in different media follows the order HCl (4 minutes with 107 mA) > PBS (11 minutes with 27 mA) > NaOH (45 minutes with 146 mA) for 3 mg of graphite rod exfoliation at +7 V. The exfoliated graphene oxide (GO) solution was sonicated for 15 minutes to obtain a uniform dispersion of the GO followed by successive washing with double distilled water, ethanol, acetone and filtration by centrifuging at 8000 rpm for 5 minutes. The final product was dried at 45 °C for 2 hours. The product was used for electrochemical and other characterizations by XRD, UV-vis, PL and SEM techniques.

2.3. Fabrication of a GO–AuNP modified glassy carbon electrode

For GCE surface modification by a drop casting method, 1.5 mg GO, obtained from pencil graphite exfoliation, was dispersed in 1 mL DMF followed by sonication for 1 hour. 2 μL of the mixture is drop cast on the GCE and dried at an ambient temperature for 30 minutes. The AuNP was then deposited by electro reduction of HAuCl4·nH2O by potential cycling in the window 0 to −0.6 V for 20 cycles. For electrochemical modification of GO on the GCE, 3 mg GO in 5 mL PBS was taken and potential cycled in the window 0 to −1.6 V for 20 cycles. This step again was followed by AuNP deposition similar to that of the drop casting method.

3. Results and discussion

3.1. Characterization of exfoliated graphene oxide

The CV curves of the GCE modified using the PGO, HGO and NGO by the drop casting method are recorded in the presence of 1 mM [Fe(CN)6]3−/4− redox probe in PBS (pH 7.4), Fig. 1. All composites show increased peak currents compared to the unmodified GCE, however differences exists between their CV profiles.
image file: c5ra11723b-f1.tif
Fig. 1 CV behaviors of GCE (curve a) modified using graphene oxide obtained by the electrical exfoliation of pencil graphite in PBS (curve b), HCl (curve c), and NaOH (curve d). The GO is dispersed in DMF and drop cast on the GCE and dried at ambient temperature. Measurements are made in the presence of [Fe(CN)6]3−/4− in PBS (pH 7.4) at a scan rate of 50 mV s−1.

For instance, the GCE–PGO showed diffused peaks with very low peak currents, while the GCE–HGO and GCE–NGO showed sharp and reversible peaks. Generally, the charge transfer from the [Fe(CN)6]3−/4− to the GO modified surface decreases due to electrostatic repulsion from the intrinsic functional groups (epoxide, acid, hydroxyl) of GO and [Fe(CN)6]3−/4−. Hence, increased charge transfer in the presence of [Fe(CN)6]3−/4− for the GCE–HGO and GCE–NGO indicates the formation of GO with fewer functional groups. The nature of these graphene oxides is further characterized by UV. The UV shows two peaks at ∼227 (arising from the π–π* transition of the atomic C–C bonds) and ∼250 nm (n–π* transitions of aromatic C–C bonds27), respectively, suggesting the introduction of oxy functional groups, Fig. S1. More interestingly, while the NGO and HGO show only two absorption peaks (220 and 250 nm), the PGO shows three absorption peaks at 220, 250 and 314 nm, respectively, indicating higher conjugation of the pi electron network in the PGO than in the other two composites.67 All samples exhibited predominantly D and G bands29,32,33 at 1300 and 1500 cm−1, respectively, in Raman spectra. Both the D and G bands arise from the double resonance effects at graphene defects. Both bands are blue shifted by 10 cm−1 with weak intensities for the HGO indicating high exfoliation of graphite in the HCl medium. Methods of graphene oxide or graphene preparation have significant effects on the positions of the D, G and 2D bands in the Raman spectra, Fig. 2A, similar to that reported for few-layer graphenes prepared by epitaxial growth on SiC, which shows a blue shifted G-band (ca. 20 cm−1) and 2D bands (ca. 60 cm−1) compared to the exfoliated graphene.66 The shifts in the position of Raman bands of three different GOs indicate a significant effect of the medium used for the exfoliation. The graphenization is very high in NaOH compared to in the HCl and PBS. The ratio of ID/IG expresses the sp2/sp3 carbon ratio manifesting on the measure of disorder34 at the edges, charge distribution and wrinkle nature. The highest ratio of ID/IG (1.12) is observed for the PGO compared to the HGO (0.984) and NGO (0.314), suggesting the introduction of oxygen functionality, which increased the disordered corner edges in the PGO. These observations indicate the fact that more graphite flakes formed in HCl and NaOH. Photoluminescence shows a triplet peak for these graphene sheets, Fig. S2. Among these three, the PGO showed maximum PL emission, indicating the highest carrier–carrier scattering over the electron phonon scattering. It may be noted that the shape of the PL spectra highly depended on the size and shape of the quantum sized carbon networks.68,69


image file: c5ra11723b-f2.tif
Fig. 2 Raman spectra (A) and XRD patterns (B) of PGO (curve a), HGO (curve b) and NGO (curve c).

The X-ray diffraction patterns of PGO, HGO and NGO are presented in Fig. 2B. The broadening of the Bragg’s peak indicates the formation of crystalline graphene, whose size is calculated using the Scherrer formula D = /βs[thin space (1/6-em)]cos[thin space (1/6-em)]θ, where D is the average size of the crystal, K is the shape dependent Scherrer’s constant, λ is the wavelength of radiation, βs is the full peak width at half maximum and θ is the diffraction angle.36 Using the full width half maximum (FWHM) of the (111) peak, the calculated crystal sizes of PGO, HGO and NGO are 1.4, 21 and 2.3 nm. The crystal sizes calculated from the ID/IG ratio using the formula La = 2.4 × 10−10λ4[ID/IG]−1 are 3.8, 4.1 and 0.7 nm, respectively. SEM images of the PGO, HGO and NGO are presented in Fig. 3. Highly disintegrated sheets formed in the HCl medium, whereas smooth sheets are obtained in NaOH. The sheets prepared in PBS appear a little rougher than those obtained in NaOH. That is, the ID/IG ratio values observed corroborate well to the SEM morphological features. The highest ID/IG ratio, smaller crystal size (from XRD measurements), and maximum PL peak intensity observed for the PGO suggest the more hydrophilic nature of the PGO than the NGO (80.2°) and HGO (92.3°), and was confirmed by the highest contact angle of 108.9°, Fig. S3.


image file: c5ra11723b-f3.tif
Fig. 3 SEM images of GO obtained from electrical exfoliation of graphite in (A) HCl; (B) phosphate buffer pH 7.4 and (C) NaOH.

The PGO is used to modify the GCE and is tested for simultaneous detection of the DA, UA and AA. Although multiple peaks are obtained, the peaks are not well separated on the GO. Only a single reversible peak corresponding to DA in the potential region 0 to 0.3 V is observed, Fig. 4A, curve a.


image file: c5ra11723b-f4.tif
Fig. 4 Simultaneous detection of 1 mM concentrations of dopamine, ascorbic acid and uric acid in PBS (pH 7.4). In the absence (A) and presence (B) of AuNP on the PGO (curve a) and PErGO (curve b) modified GCEs.

3.2. Behavior of electrochemically deposited ErGO in the presence of [Fe(CN)6]3−/4−

Since the method of surface preparation greatly influences the detection of the target analytes, in this work graphene is deposited by electrochemically reducing the PGO in the potential window 0 to −1.6 V (20 cycles) in phosphate buffer, to modify the GCE surface with ErGO, named as GCE–PErGO.

Fig. 5A depicts the comparative CV profiles of the GCE modified using the PGO (drop cast, curve b) and PGO–AuNP (curve c) measured in the presence of [Fe(CN)6]3−/4−. The peak currents decrease due to electrostatic repulsion from the intrinsic functional groups in the prepared GO. Upon deposition of AuNP, the peak currents increase nearly equivalent to the unmodified GCE because of electrocatalysis. Similarly, Fig. 5B presents the CV behaviors of the GCE (curve a) modified by electro reduction of GO by the potential cycling to form GCE–PErGO (curve b) and GCE–PErGO–AuNP (curve c). It may be noted that the current for the GCE–PErGO is increased by 50% compared to the CV profile of the GCE–PGO, indicating the electrochemical reduction of functional groups on the PGO.67 Application of the GCE–PErGO for the simultaneous detection of DA, AA, and UA showed a larger reversible peak for the DA, which is flanked by the small and irreversible peaks for the AA and UA, Fig. 4A, curve b. Recently, metal nanoparticle–graphene composites have shown a promising performance in the field of biosensors, however methods of preparation again proved to influence the sensor performance.67 It is to note that the peak current magnitude for GCE–PGO–AuNP and GCE–PErGO–AuNP are nearly the same. No significant changes in the CV profiles of these two modified GCEs are observed. This is attributed to the even deposition of gold nanoparticles on both the GCE–PGO and GCE–PErGO. This is possible because the GCE–PGO surface is prepared by the drop casting method, which uses volatile DMF solvent and the exposed PGOs are encapsulated by the AuNPs. A similar process is applicable to the GCE–PErGO surface as well, hence only AuNPs are in contact with the [Fe(CN)6]3−/4− for charge transfer, resulting in similar CV behaviors. The SEM images of PGO, PErGO and PErGO–AuNP are presented in Fig. 6. The electro reduction of PGO (Fig. 6A) results in the formation of clear, silky, wrinkled granules of PErGO (Fig. 6B) and the AuNPs are evenly deposited on the PErGO (Fig. 6C).


image file: c5ra11723b-f5.tif
Fig. 5 CV behaviors of GCE (curve a), (A) the GCE modified by PGO by drop casting (curve b) and followed by electrochemically deposited AuNP (curve c), (B) CV behaviors of GCE (curve a), modified by the electrochemical reduction of PGO (PErGO) by potential cycling (curve b), followed by electrochemically deposited AuNP (curve c). Measurements are made in the presence of 1 mM [Fe(CN)6]3−/4− in PBS (pH 7.4) at a scan rate 50 mV s−1.

image file: c5ra11723b-f6.tif
Fig. 6 SEM images of PGO (A), PErGO (B) and PErGO–AuNP (C) films.

Both the PGO–AuNP and PErGO–AuNP modified GCEs are tested for the simultaneous detection of DA, AA, and UA. The peaks are well separated on both the GO–AuNP surfaces, however, significant differences are clear between the two CV profiles, Fig. 4B. The GCE–PErGO–AuNP surface exhibits well defined peaks for all these analytes in CV. The CV peak current increases for the AA and UA, whereas it decreases for the DA. While the AA peak potential remains the same at 0.01 V on both GCE–PGO–AuNP and GCE–PErGO–AuNP, the peak potentials for the DA and UA on the GCE–PErGO are shifted positively by ∼0.1 V. The positive shifts of peak potentials for the DA and UA are attributed to the oxidation products of these compounds on the PErGO–AuNP and repulsion of π electrons on the reduced GO and aromatic π electrons in the DA and UA. The AA does not have π electron and, hence no shift in the peak potential observed. The presence of AuNP suppresses the capacitive current observed for the GCE–PGO–AuNP in the potential region where the target analytes are reacting. In order to study the effect of concentration of each analyte individually, a more sensitive DPV technique is used.

3.3. Effect of analyte concentrations

The effect of target analyte concentration is studied using both the GCE–PGO–AuNP (Fig. S4) and GCE–PErGO–AuNP (Fig. 7A–C) by varying the concentration of one analyte while the concentrations of the other two analytes are kept constant. When the GCE–PGO–AuNP surface is used, the charging current in the potential region of the non-sensing analytes (whose concentrations kept constant) increases with increasing concentration of the target analyte of interest. In contrast, on the GCE–PErGO–AuNP the charging current remains unaltered when the concentration of target analyte of interest is increased. Hence, for further analysis, the GCE–PErGO–AuNP is used. Direct proportionality between the analyte concentration and the current signal is noticed over a wide concentration range studied, 1 nM to 5000 μM. The linear relationships are given by the following equations.
 
i = 0.0144 AM−1 × [AA] + 3.92 × 10−6 A || (r2 = 0.995) (1)
 
i = 0.0253 AM−1 × [UA] + 2.77 × 10−6 A || (r2 = 0.994) (2)
 
i = 0.0412 AM−1 × [DA] + 7.83 × 10−6 A || (r2 = 0.985) (3)

image file: c5ra11723b-f7.tif
Fig. 7 Selective detection of various concentrations of ascorbic acid (A), uric acid (B) and dopamine (C) at GCE–PErGO–AuNP in phosphate buffer by DPV measurement in the presence of excess concentration of other analytes. Inset: current versus concentration plots of the respective analytes.

It is observed from the literature survey on the enzymatic detection of dopamine70 that the detection limit and sensitivity depend significantly on the procedure used for the immobilization matrix. Michaelis–Menten (MM) kinetic parameters KM, Vmax, and kcat reveal the influences of the physical and chemical properties of the surface on the efficiency of the catalytic reactions. The Michaelis–Menten (MM) constant, KM, is defined as the substrate concentration up to which the current linearly increases, Vmax is the maximum rate of the enzymatic reaction and kcat is the turnover number of the enzyme. Since the GO–AuNP composite behaves similarly to the enzyme, the MM kinetics are applied to evaluate the parameter, KM. Respective Lineweaver–Burk plots for the GCE–PGO–AuNP and GCE–PErGO–AuNP are shown in Fig. S5. From the intercepts and slopes of Fig. S5, the calculated KM values are listed in Table S1. For the DA detection, the observed KM values are 0.07 and 110 mM at the GCE–PGO–AuNP and GCE–PErGO–AuNP surfaces, respectively. The higher KM observed for the GCE–PErGO–AuNP suggests enhanced diffusion restriction properties, resulting from the electrostatic repulsions between the π electrons in the PErGO and dopamine π electrons. A similar observation is also made for AA and UA as noticed from the KM values, Table S1. From eqn (1)–(3), a higher sensitivity of 0.0412 AM−1 L−1 is obtained for DA compared to the AA and UA. Hence, the GCE–PErGO–AuNP sensor is more selective for the DA than for AA and UA. Furthermore, the GCE–PGO–AuNP showed quick saturation at concentrations below 10 mM for DA, Fig. S4B. The lowest detection limits and the dynamic ranges are given in Table S1 and comparison with the literature reports is given in Table S2. It is noteworthy that the GCE–PErGO–AuNP shows a wide linear range, and a lower detection limit than the literature reports. Fig. S6 presents the reproducibility of AA, DA and UA at the GCE–PErGO–AuNP surface. It is noted that the observed relative standard deviation (RSD) for four time repetition of the AA (0.11), DA (0.17) and UA (0.12) detections suggests the high reproducibility and stability of this sensor device.

3.4. Real sample analysis

The GCE–PErGO–AuNP surface is then used for analysing the content of AA in amla juice, vitamin C tablets (obtained from medical shops in our region), UA in urine and DA in commercial dopamine hydrochloride injections (purchased from medical shops in our region) using simple linear sweep voltammetry (LSV). Fig. 8A compares the sensor response for the commercially obtained AA (1 mM, curve b) with concentrations of AA in the real samples such as vitamin C tablet (curve c) and amla juice (curve d). For this purpose, 0.8 mg (1 mM) vitamin C tablet and 500 μL of amla juice is diluted in 5 mL PBS. It is evidenced that the sensor discriminates well between different concentrations of AA in different commercial samples. Similar experiments were undertaken for the detection of UA (Fig. 8B) in urine and DA (Fig. 8C) in commercial dopamine injection. The sensor behavior is compared with the clinical data, Fig. 8. From Fig. 8B and C, it is evident that the sensor showed nearly equal current signals for both the commercial UA, DA and the real samples. In Fig. 8A, the AA signal for the vitamin C decreases slightly, whereas an increased signal is noticed for the ascorbic acid in the amla juice.
image file: c5ra11723b-f8.tif
Fig. 8 (A) Comparison of LSV behaviors of the GCE–PErGO–AuNP in PBS buffer (curve a) for detections of ascorbic acid in commercial (curve b), real samples of vitamin C (curve c) and amla juice (curve d). (B) Comparative LSV curves for the commercial uric acid (curve b) and uric acid present in the urine sample (curve c). (C) Dopamine detection commercial (curve b) and dopamine hydrochloride injection (curve c). LSV is recorded at a scan rate 50 mV s−1.

4. Conclusions

Three media have been tested for electrical exfoliation of pencil graphite to produce graphene oxide cost-effectively. Among the three media used, the phosphate buffer with pH 7.4 is the best suited for producing high quality and few layered graphene oxide compared to the HCl and NaOH. The green synthesis of graphene oxide by electrical exfoliation and gold nanoparticle by electro-reduction is a simple method. The GCE–PErGO–AuNP exhibits well defined and separated peaks for AA, DA and UA compared to the GCE–PGO–AuNP. The gold nanoparticle is evenly deposited on both GCE–PGO and GCE–PErGO irrespective of the method of the film formation on the GCE, indicating the fact that DMF is a good solvent which is evaporated completely and GO are capped by the AuNPs. Although this is common for both GCE–PGO–AuNP and GCE–PErGO–AuNP, indicated by their similar CV behaviors, the presence of AuNP on the GCE–PErGO eliminates the charging current contribution completely in DPV, which is essentially required for the development of more sensitive biosensors for other biotechnological applications. The lowest detection limit for dopamine observed is 10 nM with a linear range of 10 nM to 3000 μM.

Acknowledgements

The authors acknowledge the Department of Industrial Chemistry and the Department of Physics, Alagappa University for providing material characterization facilities. The authors acknowledge University Grants Commission India for financial support. P. N. Manikandan acknowledges the Department of Science and Technology of India for awarding the INSPIRE Fellowship (IF 140744).

References

  1. J. Ping, J. Wu, Y. Wang and Y. Ying, Biosens. Bioelectron., 2012, 34, 70 CrossRef CAS PubMed.
  2. A. Ciszewski and G. Milczarek, Anal. Chem., 1999, 71, 1055 CrossRef CAS PubMed.
  3. A. Salimi, K. Abdi and G. R. Khayatian, Microchim. Acta, 2004, 144, 161 CrossRef CAS.
  4. Y. Zhao, Y. Gao, D. Zhan, H. Liu, Q. Zhao, Y. Kou, Y. Shao, M. Li, Q. Zhuang and Z. Zhu, Talanta, 2005, 66, 51 CrossRef CAS PubMed.
  5. A. Ensafi, M. Taei, T. Khayamian and A. Arabzadeh, Sens. Actuators, B, 2010, 147, 213 CrossRef CAS PubMed.
  6. M. Mallesha, R. Manjunatha, C. Nethravathi, G. S. Suresh, M. Rajamathi, J. S. Melo and T. V. Venkatesha, Bioelectrochemistry, 2011, 81, 104 CrossRef CAS PubMed.
  7. U. Yogeswaran, S. Thiagarajan and S. M. Chen, Anal. Biochem., 2007, 365, 122 CrossRef CAS PubMed.
  8. A. Asan and I. Isildak, J. Chromatogr., A, 2003, 988, 145 CrossRef CAS.
  9. S. C. Moldoveanu and M. Kiser, J. Chromatogr., A, 2007, 1141, 90 CrossRef CAS PubMed.
  10. M. J. Schoning, M. Jacobs, A. Muck, D. T. Knobbe, J. Wang, M. Chatrathi and S. Spillmann, Sens. Actuators, B, 2005, 108, 688 CrossRef PubMed.
  11. S. R. Ali, P. R. Parajuli, Y. Balogun, Y. F. Ma and H. X. He, Sensors, 2008, 8, 8423 CrossRef CAS PubMed.
  12. D. Lakshmi, M. J. Whitcombe, F. Davis, P. S. Sharma and B. B. Prasad, Electroanalysis, 2011, 23, 305 CrossRef CAS PubMed.
  13. A. Malinauskas, R. Garjonyte, R. Mazeikiene and I. Jureviciute, Talanta, 2004, 64, 121 CrossRef CAS PubMed.
  14. P. Ramesh and S. Sampath, Electroanalysis, 2004, 16, 866 CrossRef CAS PubMed.
  15. X. H. Lin, Y. F. Zhang, W. Chen and P. Wu, Sens. Actuators, B, 2007, 122, 309 CrossRef CAS PubMed.
  16. A. A. Ensafi, M. Taei and T. Khayamian, J. Electroanal. Chem., 2009, 633, 212 CrossRef CAS PubMed.
  17. C. Lee, X. D. Wei, J. W. Kysar and J. Hone, Science, 2008, 321, 385 CrossRef CAS PubMed.
  18. P. R. Nair, P. Blake, A. N. Grigorenko, K. S. Novoselov, T. J. Booth, T. Stauber, N. M. R. Peres and A. K. Geim, Science, 2008, 320, 1308 CrossRef PubMed.
  19. M. D. Stoller, S. J. Park, Y. W. Zhu, J. H. An and R. S. Ruoff, Nano Lett., 2008, 8, 3498 CrossRef CAS PubMed.
  20. N. Mohanty and V. Berry, Nano Lett., 2008, 8, 4469 CrossRef CAS PubMed.
  21. P. Wu, Q. Shao, Y. Hu, J. Jin, Y. Yin, H. Zhang and C. Cai, Microchim. Acta, 2010, 55, 8606 CAS.
  22. C. Zhu and S. Dong, Nanoscale, 2013, 5, 1753 RSC.
  23. S. Thiagarajan and S. M. Chen, Talanta, 2007, 74, 212 CrossRef CAS PubMed.
  24. C. F. Tang, S. A. Kumar and S. M. Chen, Anal. Biochem., 2008, 380, 174 CrossRef CAS PubMed.
  25. G. Wang, J. Sun, W. Zhang, S. F. Jiao and B. Fang, Microchim. Acta, 2009, 164, 357 CrossRef CAS.
  26. Y. Z. Zhang, Y. Pan, S. Su, L. Zhang, S. P. Li and M. W. Shao, Electroanalysis, 2007, 19, 1695 CrossRef CAS PubMed.
  27. K. S. Prasad, G. Muthuraman and J. Zen, Electrochem. Commun., 2008, 10, 559 CrossRef PubMed.
  28. Y. Liu, J. S. Huang, H. Q. Hou and T. Y. You, Electrochem. Commun., 2008, 10, 1431 CrossRef CAS PubMed.
  29. J. H. Chen, J. Zhang, X. H. Lin, H. Y. Wan and S. Zhang, Electroanalysis, 2007, 19, 612 CrossRef CAS PubMed.
  30. H. Yao, Y. Y. Sun, X. H. Lin, Y. H. Tang and L. Y. Huang, Electrochim. Acta, 2007, 52, 6165 CrossRef CAS PubMed.
  31. R. Aguilar, M. M. Dávila, M. P. Elizalde, J. Mattusch and R. Wennrich, Electrochim. Acta, 2004, 49, 851 CrossRef CAS PubMed.
  32. A. H. Liu, I. Honma and H. S. Zhou, Biosens. Bioelectron., 2007, 23, 74 CrossRef CAS PubMed.
  33. J. S. Huang, Y. Liu, H. Q. Hou and T. You, Biosens. Bioelectron., 2008, 24, 632 CrossRef CAS PubMed.
  34. D. Zheng, J. S. Ye, L. Zhou, Y. Zhang and C. Z. Yu, J. Electroanal. Chem., 2009, 625, 82 CrossRef CAS PubMed.
  35. W. A. de Heer, C. Berger, X. S. Wu, P. N. First, E. H. Conrad, X. B. Li, T. B. Li, M. Sprinkle, J. Hass, M. L. Sadowski, M. Potemski and G. Martinez, Solid State Commun., 2007, 143, 92 CrossRef CAS PubMed.
  36. K. V. Emtsev, A. Bostwick, K. Horn, J. Jobst, G. L. Kellogg, L. Ley, J. L. McChesney, T. Ohta, S. A. Reshanov, J. Rohrl, E. Rotenberg, A. K. Schmid, D. Waldmann, H. B. Weber and T. Seyller, Nat. Mater., 2009, 8, 203 CrossRef CAS PubMed.
  37. E. Rolling, G. H. Gweon, S. Y. Zhou, B. S. Mun, J. L. McChesney, B. S. Hussain, A. Fedorov, P. N. First, W. A. de Heer and A. Lanzara, J. Phys. Chem. Solids, 2006, 67, 2172 CrossRef PubMed.
  38. C. Berger, Z. M. Song, X. B. Li, X. S. Wu, N. Brown, C. Naud, D. Mayo, T. B. Li, J. Hass, A. N. Marchenkov, E. H. Conrad, P. N. First and W. A. de Heer, Science, 2006, 312, 1191 CrossRef CAS PubMed.
  39. (a) P. W. Sutter, J. I. Flege and E. A. Sutter, Nat. Mater., 2008, 7, 406 CrossRef CAS PubMed; (b) K. S. Kim, Y. Zhao, H. Jang, S. Y. Lee, J. M. Kim, J. H. Ahn, P. Kim, J. Y. Choi and B. H. Hong, Nature, 2009, 457, 706 CrossRef CAS PubMed.
  40. A. Reina, X. T. Jia, J. Ho, D. Nezich, H. B. Son, V. Bulovic, M. S. Dresselhaus and J. Kong, Nano Lett., 2009, 9, 30 CrossRef CAS PubMed.
  41. X. S. Li, W. W. Cai, J. H. An, S. Kim, J. Nah, D. X. Yang, R. Piner, A. Velamakanni, I. Jung, E. Tutuc, S. K. Banerjee, L. Colombo and R. S. Ruoff, Science, 2009, 324, 1312 CrossRef CAS PubMed.
  42. A. Dato, V. Radmilovic, Z. H. Lee, J. Phillips and M. Frenklach, Nano Lett., 2008, 8, 2012 CrossRef CAS PubMed.
  43. A. N. Obraztsov, Nat. Nanotechnol., 2009, 4, 212 CrossRef CAS PubMed.
  44. S. Stankovich, D. A. Dikin, R. D. Piner, K. A. Kohlhaas, A. Kleinhammes, Y. Jia, Y. Wu, S. T. Nguyen and R. S. Ruoff, Carbon, 2007, 45, 1558 CrossRef CAS PubMed.
  45. S. Gilje, S. Han, M. Wang, K. L. Wang and R. B. Kaner, Nano Lett., 2007, 7, 3394 CrossRef CAS PubMed.
  46. D. Li, M. B. Muller, S. Gilje, R. B. Kaner and G. G. Wallace, Nat. Nanotechnol., 2008, 3, 101 CrossRef CAS PubMed.
  47. X. B. Fan, W. C. Peng, Y. Li, X. Y. Li, S. L. Wang, G. L. Zhang and F. B. Zhang, Adv. Mater., 2008, 20, 4490 CrossRef CAS PubMed.
  48. H. C. Schniepp, J. L. Li, M. J. McAllister, H. Sai, M. Herrera-Alonso, D. H. Adamson, R. K. Prud’homme, R. Car, D. A. Saville and I. A. Aksay, J. Phys. Chem. B, 2006, 110, 8535 CrossRef CAS PubMed.
  49. M. Zhou, Y. L. Wang, Y. Zhai, J. Zhai, W. Ren, F. Wang and S. Dong, Chemistry, 2009, 15, 6116 CrossRef CAS PubMed.
  50. (a) E. Casero, C. Alonso, L. Vazquez, M. D. Petit-Domínguez, A. M. Parra-Alfambra, M. de la Fuente, P. Merino, S. Álvarez-García, A. de Andrés, F. Pariente and E. Lorenzo, Electroanalysis, 2013, 25, 154 CrossRef CAS PubMed; (b) K. S. Novoselov, A. K. Geim, S. V. Morozov, D. Jiang, Y. Zhang, S. V. Dubonos, I. V. Grigorieva and A. A. Firsov, Science, 2004, 306, 666 CrossRef CAS PubMed.
  51. C. Berger, Z. Song, X. Li, X. Wu, N. Brown, C. Naud, D. Mayou, T. Li, J. Hass, A. N. Marchenkov, E. H. Conrad, P. N. First and W. A. de Heer, Science, 2006, 312, 1191 CrossRef CAS PubMed.
  52. D. A. Dikin, S. Stankovich, E. J. Zimney, R. D. Piner, G. H. B. Dommett, G. Evmenenko, S. T. Nguyen and R. S. Ruoff, Nature, 2007, 448, 457 CrossRef CAS PubMed.
  53. X. L. Li, X. R. Wang, L. Zhang, S. W. Lee and H. J. Dai, Science, 2008, 319, 1229 CrossRef CAS PubMed.
  54. X. L. Li, G. Y. Zhang, X. D. Bai, X. M. Sun, X. R. Wang, E. G. Wang and H. J. Dai, Nat. Nanotechnol., 2008, 3, 538 CrossRef CAS PubMed.
  55. V. C. Tung, M. J. Allen, Y. Yang and R. B. Kaner, Nat. Nanotechnol., 2008, 4, 25 CrossRef PubMed.
  56. H. C. Schniepp, J. L. Li, M. J. McAllister, H. Sai, M. Herrera-Alonso, D. H. Adamson, R. K. Prud’homme, R. Car, D. A. Saville and I. A. Aksay, J. Phys. Chem. B, 2006, 110, 8535 CrossRef CAS PubMed.
  57. Y. Qian, C. Y. Wang and Z. G. Le, Appl. Surf. Sci., 2011, 257, 10758 CrossRef CAS PubMed.
  58. M. Fang, K. G. Wang, H. B. Lu, Y. L. Yang and S. Nutt, J. Mater. Chem., 2010, 20, 1982 RSC.
  59. H. He and C. Gao, Chem. Mater., 2010, 22, 5054 CrossRef CAS.
  60. F. Y. Zhang, Z. H. Wang, Y. Z. Zhang, Z. X. Zheng, C. M. Wang, Y. L. Du and W. C. Ye, Int. J. Electrochem. Sci., 2012, 7, 19 Search PubMed.
  61. K. Zhou, Y. Zhu, X. Yang and C. Li, Electroanalysis, 2010, 22, 259 CrossRef CAS PubMed.
  62. J. Li, J. Yang, Z. Yang, L. Li, Y. Yu, Q. Xu and X. Hu, Anal. Methods, 2012, 4, 1725 RSC.
  63. C. Wang, F. Ye, H. Wu and Y. Qian, Int. J. Electrochem. Sci., 2013, 8, 2440 CAS.
  64. J. Du, R. Yue, F. Ren, Z. Yao, F. Jiang, P. Yang and Y. Du, Gold Bull., 2013, 46, 137 CrossRef.
  65. N. Liu, F. Luo, H. Wu, Y. Liu, C. Zhag and J. Chen, Adv. Funct. Mater., 2008, 18, 1518 CrossRef CAS PubMed.
  66. K. S. Rao, J. Senthilnathan, Y. F. Liu and M. Yoshimura, Sci. Rep., 2013, 4, 4237 Search PubMed.
  67. V. Dharuman, J. H. Hahn, K. Jayakumar and W. Tang, Microchim. Acta, 2013, 114, 590 CAS.
  68. S. Xu, L. Yong and P. Wu, J. Am. Chem. Soc., 2013, 5, 654 CAS.
  69. S. Kim, S. W. Hwang, M. Kim, D. Y. Shin, D. H. Shin, C. O. Kim, S. B. Yang, J. H. Park, E. Hwang, S. Choi, G. Ko, S. Sim, C. Sone, H. J. Choi, S. Bae and B. H. Hong, ACS Nano, 2012, 6, 8203 CrossRef CAS PubMed.
  70. S. Tembe, M. Karve, S. Inamdar, S. Haram, J. Melo and S. F. D’Souza, Anal. Biochem., 2006, 349, 72 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: UV, contact angle measurement, CV and DPV. See DOI: 10.1039/c5ra11723b

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.